Global Male Infertility Market to Reach US$ 6.2 Billion by 2032, Stimulated by Rising Cases of Male Infertility Worldwide

August 16, 2023 | Healthcare

According to the latest report by IMARC Group, titled “Male Infertility Market Report by Test Type (Sperm Agglutination, DNA Fragmentation Technique, Oxidative Stress Analysis, Computer Assisted Semen Analysis, Sperm Penetration Assay, and Others), Treatment (Medication, Assisted Reproductive Technology and Varicocele Surgery), Distribution Channel (Hospitals Pharmacies, Pharmacies and Drug Stores, Online Pharmacies), End User (Hospitals and Clinics, Fertility Centers, Research Institutes, and Others), and Region 2024-2032,” the global male infertility market size reached US$ 4.0 Billion in 2023. Male infertility refers to a medical condition wherein a man experiences difficulties in impregnating a fertile female partner, resulting in the inability or reduced likelihood of conceiving a child. It is caused due to various factors, including low sperm count, poor sperm motility, abnormal sperm morphology, hormonal imbalances, genetic disorders, testicular damage, and blockages in the reproductive system. Its treatment involves evaluating semen parameters, such as sperm count, motility, and morphology, assessing hormonal profiles, and conducting specialized tests, like genetic screening, hormone testing, and imaging studies. Besides this, it can also be treated using hormonal therapy, surgical procedures to correct blockages and abnormalities, and assisted reproductive technologies, such as in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI).

Global Male Infertility Market Trends:

The increasing prevalence of male infertility around the world due to changing lifestyles, stress, poor nutrition, exposure to environmental toxins, and aging represents one of the significant factors propelling the market growth. Additionally, the rising awareness among individuals about infertility issues and the increasing acceptance of treatments, prompted by reduced societal stigma, are driving the demand for male infertility solutions. The rising demand for personalized and precision medicine in infertility treatment is also contributing to market growth. Moreover, advancements in diagnostic procedures and the rising adoption of treatments like assisted reproductive technologies (ART) and in-vitro fertilization are further bolstering the growth of the market. The advent of cutting-edge technologies in sperm analysis and the development of novel drug therapies are offering promising market growth opportunities to industry investors. Furthermore, government initiatives promoting fertility treatment and increased investment in research and development (R&D) are impelling the market growth. The introduction of supportive policies, such as insurance coverage for infertility treatments and reimbursement options, is encouraging individuals and couples to seek medical assistance for male infertility. Looking forward, the market value is projected to reach US$ 6.2 Billion by 2032, expanding at a CAGR of 4.79% during 2024-2032.

Market Summary:

  • On the basis of the test type, the market has been segmented into sperm agglutination, DNA fragmentation technique, oxidative stress analysis, computer assisted semen analysis, sperm penetration assay, and others. DNA fragmentation technique currently accounts for the majority of the total market share.
  • Based on the treatment, assisted reproductive technology and varicocele surgery represents the largest market segment, followed by medication.
  • On the basis of the distribution channel, the market has been divided into hospitals pharmacies, pharmacies and drug stores, and online pharmacies. At present, hospitals pharmacies exhibit a clear dominance in the market.
  • Based on the end user, the market has been segregated into hospitals and clinics, fertility centers, research institutes, and others. Fertility centers exhibit a clear dominance in the market.
  • Region-wise, the market has been classified into North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. Amongst these, Europe enjoys the leading position in the market.
  • The competitive landscape of the market has also been examined, with some of the key players being Andrology Solutions, CinnaGen Co., Halotech DNA, SCSA Diagnostics Inc., Vitrolife, Zydus Lifesciences Limited, Intas Pharmaceuticals Ltd. and Endo International plc.

Report Coverage:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Segment Coverage Test Type, Treatment, Distribution Channel, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Andrology Solutions, CinnaGen Co., Halotech DNA, SCSA Diagnostics Inc., Vitrolife, Zydus Lifesciences Limited, Intas Pharmaceuticals Ltd. and Endo International plc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

134 N 4th St.
Brooklyn, NY 11249, USA
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Male Infertility Market to Reach US$ 6.2 Billion by 2032, Stimulated by Rising Cases of Male Infertility Worldwide
Purchase options

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-713-2163


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More